CN112067642A - Method for determining crystal form purity of beta-HMX crystal form standard substance - Google Patents

Method for determining crystal form purity of beta-HMX crystal form standard substance Download PDF

Info

Publication number
CN112067642A
CN112067642A CN202010856686.XA CN202010856686A CN112067642A CN 112067642 A CN112067642 A CN 112067642A CN 202010856686 A CN202010856686 A CN 202010856686A CN 112067642 A CN112067642 A CN 112067642A
Authority
CN
China
Prior art keywords
hmx
beta
crystal form
test
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010856686.XA
Other languages
Chinese (zh)
Other versions
CN112067642B (en
Inventor
陈智群
康莹
刘可
潘�清
王民昌
王明
赵娟
李晓宇
栾洁玉
朱一举
张皋
常海
苏鹏飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xian Modern Chemistry Research Institute
Original Assignee
Xian Modern Chemistry Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xian Modern Chemistry Research Institute filed Critical Xian Modern Chemistry Research Institute
Priority to CN202010856686.XA priority Critical patent/CN112067642B/en
Publication of CN112067642A publication Critical patent/CN112067642A/en
Application granted granted Critical
Publication of CN112067642B publication Critical patent/CN112067642B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • G01N23/207—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • G01N23/20008—Constructional details of analysers, e.g. characterised by X-ray source, detector or optical system; Accessories therefor; Preparing specimens therefor
    • G01N23/2005—Preparation of powder samples therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/42—Measuring deposition or liberation of materials from an electrolyte; Coulometry, i.e. measuring coulomb-equivalent of material in an electrolyte
    • G01N27/423—Coulometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/16—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using titration

Abstract

The invention provides a method for determining a crystal form purity value of a beta-HMX crystal form standard substance, which specifically comprises the following steps: step one, extracting a powder sample; step two, testing beta-HMX, acetone, moisture and other organic impurities in the beta-HMX crystal form standard substance respectively; testing X-ray powder diffraction, and calculating by full spectrum fitting to obtain the relative content of the beta-HMX crystal form in all HMX of different crystal forms; nuclear magnetic resonance testing, wherein a nuclear magnetic resonance hydrogen spectrum is added with a fumaric acid standard method with known purity for testing the content of acetone; warm stage-coulomb test, warm stage-coulomb titration method is used for testing the trace moisture content; liquid chromatography test, wherein a liquid chromatography normalization method is used for testing the content of other organic impurities; and step three, carrying out statistical analysis on the test results of the beta-HMX, acetone, moisture and other organic impurities in the beta-HMX crystal form standard substance to obtain a fixed value result. The method for determining the value is accurate, reliable and feasible, and can realize accurate value determination of the high-purity beta-HMX crystal form standard substance.

Description

Method for determining crystal form purity of beta-HMX crystal form standard substance
Technical Field
The invention belongs to the field of explosives, relates to HMX, and particularly relates to a method for determining a crystal form purity value of a beta-HMX crystal form standard substance.
Background
HMX (chemical name: 1,3,5, 7-tetranitro-1, 3,5, 7-tetraazacyclooctane) is a high-energy explosive, alpha type crystal and beta type crystal exist in HMX production, a crude product synthesized by HMX is an alpha type crystal, crystal transformation is required to be a beta type crystal, and beta-HMX is a better crystal form for application. The micro-morphology of beta-HMX isSymmetrical gem type, good free-running property and density 1.902g/cm-3Is relatively large. The micro-morphology of the alpha-HMX is sheet-shaped or needle-shaped, the flowability of the charging process is poor, and the density is 1.846g/cm-3The density is 3% lower than that of beta-HMX, the sensitivity is high, the charging safety is influenced, and the energy density is reduced. And the HMX inspection needs a beta-HMX crystal form explosive standard substance as a reference so as to ensure the consistency and traceability of the test result.
The beta-HMX crystal form standard substance can be used as a standard substance with accurate crystal form purity and uncertainty in the process of testing an HMX crystal form by using X-ray diffraction, solid ultraviolet-visible absorption spectrum, near infrared spectrum, infrared absorption spectrum, Raman spectrum, terahertz absorption spectrum and solid nuclear magnetic resonance spectrum technologies.
The beta-HMX crystal form standard substance is a high-purity crystal prepared by acetone crystallization, and four impurities exist besides the main beta-HMX: the crystal form of the impurity beta-HMX, residual solvent acetone, trace moisture and other organic impurities. The purity of the beta-HMX crystal form refers to the content of the beta-HMX in all components, and a method for determining the value of a beta-HMX crystal form standard substance is not available at present.
Chinese patent with application publication No. CN 108918701A and patent name "preparation and value determination method of hesperetin standard substance" discloses a chemical purity value determination method, but does not relate to a crystal form purity value determination method. The searched HMX crystal form test patents and papers use different spectrum techniques to identify different crystal forms, and establish working curves or quantitative models by standard substances or references, which do not solve the problems of fixed value authority and traceability of the used standard substances, such as: the application publication number is CN 110579500A, and the patent name is Chinese patent of 'a method for detecting the purity of beta-HMX crystal form based on X-ray powder diffraction technology'.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a method for determining the crystal form purity of a beta-HMX crystal form standard substance, so as to solve the technical blank in the field of determination of the crystal form purity of the beta-HMX crystal form standard substance in the prior art.
In order to solve the technical problems, the invention adopts the following technical scheme:
a method for determining a crystal form purity value of a beta-HMX crystal form standard substance specifically comprises the following steps:
step one, extracting a powder sample;
step two, testing beta-HMX, acetone, moisture and other organic impurities in the beta-HMX crystal form standard substance respectively;
the test comprises an X-ray powder diffraction test, a nuclear magnetic resonance test, a warm table-coulomb test and a liquid chromatography test;
testing X-ray powder diffraction, and calculating by full spectrum fitting to obtain the relative content of the beta-HMX crystal form in all HMX of different crystal forms;
nuclear magnetic resonance testing, wherein a nuclear magnetic resonance hydrogen spectrum is added with a fumaric acid standard method with known purity for testing the content of acetone;
warm stage-coulomb test, warm stage-coulomb titration method is used for testing the trace moisture content;
liquid chromatography test, wherein a liquid chromatography normalization method is used for testing the content of other organic impurities;
and step three, carrying out statistical analysis on the test results of the beta-HMX, acetone, moisture and other organic impurities in the beta-HMX crystal form standard substance to obtain a fixed value result.
The invention also has the following technical characteristics:
the fixed value result of the crystal form purity of the beta-HMX crystal form standard substance is determined by the crystal form purity xβ-HMXAnd uncertainty uβ-HMXAnd (4) forming.
In the first step, 7 bottles of samples are randomly extracted, the samples are divided into upper samples, middle samples and lower samples, the sampling amount is measured and numbered according to 3-4 times of the sampling amount, and 21 powder samples of the beta-HMX crystal form standard substance are tested in parallel on each component.
In the second step, the specific process of the X-ray powder diffraction test comprises the following steps:
step S20101, preparing an alpha-HMX single crystal, dissolving 2g of HMX in 20ml of a mixed solvent of acetone and water according to the volume ratio of 1: 1 to prepare a concentrated solution of HMX, filtering, placing 10ml of filtrate in a test tube, sealing a sealing film, pricking 10-15 holes with a needle, and standing at room temperature until a single crystal grows out;
step S20102, preparing a beta-HMX single crystal, dissolving 6g of HMX in 20ml of a mixed solvent of butyrolactone and dimethyl sulfoxide according to a volume ratio of 73: 27 to prepare a concentrated HMX solution, filtering, placing 10ml of filtrate in a test tube, sealing a sealing film, pricking 10-15 holes with a needle, and standing at room temperature until a single crystal grows out;
the alpha-HMX single crystal and the beta-HMX single crystal are subjected to single crystal X-ray diffraction test to obtain crystal structure parameter data of the alpha-HMX single crystal and the beta-HMX single crystal;
step S20103, placing a 500mg powder sample in an agate mortar, adding 1-2 ml of n-hexane for grinding for 1-2 min in order to inhibit crystal transformation caused by grinding, scraping off the n-hexane with a small spoon, smearing on a glass slide, placing the glass slide under a microscope of 20 times or 50 times for observation, wherein the granularity is 5-10 mu m to inhibit large extinction of crystal particles, and the quantitative sensitivity and the precision are reduced due to diffraction spectrum peak broadening caused by preferred orientation; drying in a vacuum drying oven at 40 ℃ for 3h, standing for 3-4 h for later use, and releasing stress generated by grinding to avoid peak-shaped displacement;
step S20104, performing an X-ray powder diffraction experiment according to the following test parameters: the test parameters of the powder diffractometer are 40kV in voltage, 40mA in current and Cu-K in Cu-KαThe wavelength is 1.5406nm, the sample rotates at the speed of 50 r/min during scanning, the 2 theta scanning starts at the angle of 5 degrees, ends at the angle of 90 degrees, the step width is 0.02 degree, the step time is 1s, each sample is tested on an X-ray powder diffractometer for 1 time, and 1 piece of diffraction spectrum data is obtained;
and step S20105, calculating corresponding standard diffraction spectrums by using TOPAS software according to the alpha-HMX and beta-HMX single crystal structure parameter data and the X-ray powder diffraction data of the standard substance sample, which are obtained in the step S, as input values. Based on the fact that the main crystal form of the sample is beta type, possible mixed crystals are alpha type, the sample is respectively fitted and calculated with alpha type HNIW standard crystal form diffraction spectra, and when the residual variance factor Rwp of a weighting graph is calculated in a fitting mode and is less than 15, the relative content of the beta-HMX crystal form in the sample in alpha type HMX and beta type HMX is obtained.
In the second step, the specific process of the nuclear magnetic resonance test comprises the following steps:
step S20201, weighing 0.1g of fumaric acid standard substance with known purity, accurately weighing 0.00001g of fumaric acid standard substance, weighing 1000g of deuterated dimethyl sulfoxide, accurately weighing 0.001g of deuterated dimethyl sulfoxide to prepare 0.01% of fumaric acid deuterated dimethyl sulfoxide solution as an internal standard solution, wherein the concentration of the internal standard solution is calculated by the weighed fumaric acid and deuterated dimethyl sulfoxide;
step S20202, weighing 0.1g of beta-HMX crystal form standard substance sample in a nuclear magnetic tube with the diameter of 5mm, accurately measuring the sample to 0.00001g, adding 0.6g of prepared fumaric acid solution with the volume of 0.5-0.6 ml, accurately measuring the sample to 0.0001g, sealing the sample by using a nuclear magnetic cap and a sealing film, performing ultrasonic treatment for 3-5 min, and then performing quantitative nuclear magnetic hydrogen spectrum test; the quantitative nuclear magnetic test conditions were: the resonance frequency of a nuclear magnetic spectrometer is 400-800 MHz, the temperature is 20-35 ℃, the delay time is not less than 10s, the pulse angle is 30-90 degrees, and the sampling frequency is not less than 16 times;
H2.27 is a characteristic peak of 6H on acetone,H6.06 shows a characteristic peak of 2H on fumaric acid-HC ═ CH-H6.05 is the characteristic peak for H on the HMX ring. The intensity ratio of 6 hydrogen of 1 molecule of acetone to 2 hydrogen of 1 molecule of fumaric acid is equivalent to the molar ratio of the two components, and according to the obtained nuclear magnetic spectrum, after integral treatment, the acetone content is calculated by a formula I:
Figure BDA0002646603910000041
in the formula:
X2-the content of residual solvent acetone in the sample, expressed as mass fraction;
As-integrated area of characteristic signal peak of fumaric acid;
Ax-integrated area of acetone characteristic peak;
H s1 molecule of fumaric acid characteristic peak corresponding to the number of H on the functional group, 2;
H x1, the number of H on the functional group corresponding to the characteristic peak of the molecular acetone is 6;
Mx-acetone molecular weight, 58.08;
Msfumaric acid molecular weight, 116.07;
msmass of fumaric acid solution in g;
mass of m-beta-HMX sample in g;
Psconcentration in grams/g of fumaric acid solution.
In the second step, the specific process of the warm table-coulomb test comprises the following steps:
step S203, weighing 1g of sample by using a warm table sample bottle, accurately measuring the sample to 0.002g, and sealing the sample in a warm table; setting the heating temperature at 220 ℃, keeping the temperature for 10min, starting a titration switch, and correspondingly consuming 10.712 coulomb electricity by 1g of water, wherein the water content can be calculated according to the consumed electricity.
In the second step, the specific process of the liquid chromatography test comprises the following steps:
step S204, weighing about 0.01g of sample to be accurate to 0.0002g, dissolving the sample with 1ml of acetonitrile, and diluting the sample with methanol to 50ml for chromatographic analysis; wavelength of liquid chromatography ultraviolet detector is selected to be 220nm, and chromatographic column SB-C18(Φ 4.6mm × 250mm), mobile phase V (methanol): v (water) is 60: 40, the flow rate is 1mL/min, and the sample injection amount is 5 mul; and comparing the blank of the acetonitrile methanol solution with the chromatogram of the sample solution, selecting all peaks except a solvent peak for area normalization, and calculating the content of organic impurities in the beta-HMX crystal form standard substance.
In the third step, the specific process of obtaining the fixed value result through data statistics comprises the following steps:
step S301, counting the purity value of the crystal form:
the purity of the beta-HMX crystal form is that acetone, moisture and other organic impurities are subtracted from the content of beta-HMX in two phases of alpha-HMX and beta-HMX, and a calculation formula is shown as a formula II;
Figure BDA0002646603910000061
in the formula:
xβ-HMXis the purity of beta-HMX crystal form in mass percentA score representation;
Figure BDA0002646603910000062
the average value of the relative content test results of the beta-HMX crystal form is obtained;
Figure BDA0002646603910000063
is the average of the acetone test results;
Figure BDA0002646603910000064
the average value of the moisture test results;
Figure BDA0002646603910000065
the average value of the test results of other organic impurities;
step S302, uncertainty statistics:
the uncertainty of the purity of the beta-HMX crystal form is synthesized by the uncertainty of the test of four components, and the uncertainty introduced in the test process of each component is composed of random factors and fixed factors, wherein:
the calculation formula of the experimental standard deviation of the average value of the four types of components is shown in a formula III;
Figure BDA0002646603910000066
the uncertainty introduced by the random factors is synthesized by the experimental standard deviation of the average value of the four components, and the formula is calculated and shown as the formula IV;
Figure BDA0002646603910000067
in the formula:
sβ-HMXuncertainty introduced for random factors;
Figure BDA0002646603910000071
is the experimental standard deviation of the mean value of the purity test of the beta-HMX crystal form;
Figure BDA0002646603910000072
experimental standard deviation which is the mean of the acetone content test;
Figure BDA0002646603910000073
experimental standard deviation which is the mean of the moisture content test;
Figure BDA0002646603910000074
experimental standard deviation of the mean values tested for other organic impurities;
the uncertainty introduced by the fixed factor is only the uncertainty of an internal standard substance when the acetone is subjected to fixed value by nuclear magnetism, and the uncertainties introduced by the fixed factors of other three components are ignored, so that the fixed value uncertainty is the uncertainty introduced by the random factor and the fixed factor, and the calculation formula is shown as a formula V;
Figure BDA0002646603910000075
in the formula:
uβ-HMXuncertainty for crystal form purity;
uRthe uncertainty of fumaric acid for nuclear magnetic testing is 0.00102%.
Compared with the prior art, the invention has the following technical effects:
the method for determining the value is accurate, reliable and feasible, and can realize accurate value determination of the high-purity beta-HMX crystal form standard substance.
In order to improve the quality of the fixed value, the fixed value method obtains the accurate crystal purity value of the sample through statistical random sample extraction, high-precision item fixed value and data statistical analysis, and can also be used for the crystal purity measurement of other homogeneous and heterogeneous chemical materials.
The invention relates to a nuclear magnetism micro-trace solvent test, a moisture test, a full spectrum fitting test of crystal form content and a liquid chromatogram test method of other organic impurities, which can also be used for testing multi-component and multi-phase components.
Drawings
FIG. 1 is an X-ray diffraction pattern of a sample of a beta-HMX standard.
FIG. 2 is a nuclear magnetic hydrogen spectrum of a sample of a β -HMX standard substance.
FIG. 3 is a schematic of the water extraction by the warm-table-coulometric titration method.
FIG. 4 is a liquid chromatogram of a sample of a β -HMX standard.
The meaning of the individual reference symbols in the figures is: 1-air inlet pipe, 2-air outlet pipe, 3-sealing cover, 4-sample bottle and 5-heating furnace.
The present invention will be explained in further detail with reference to examples.
Detailed Description
The invention establishes a beta-HMX crystal form standard substance crystal form purity value-fixing method, which is an accurate and traceable value-fixing method based on unique sample extraction and test methods and data statistical analysis on the basis of fully analyzing all trace components in the beta-HMX crystal form standard substance without omission.
In the present invention, the TOPAS software refers to TOtal PAttern Solution software, i.e. whole spectrum analysis software, and the TOPAS software is conventional software known in the art. The method is used for calculating standard data of a standard crystal form by using data of a single crystal and fitting a full spectrum of test data and the standard data to obtain the relative content of the crystal form.
In the present invention, the extended uncertainty of the fixed purity value of the β -HMX crystal form (confidence probability P ═ 95%): u is k Uβ-HMX(k＝2，P＝95％)。
In the invention, the purity fixed value result table of the beta-HMX crystal formThe following steps: x is the number ofβ-HMX±2uβ-HMX(k＝2，P＝95％)。
The present invention is not limited to the following embodiments, and all equivalent changes based on the technical solutions of the present invention fall within the protection scope of the present invention.
Example (b):
the embodiment provides a method for determining the crystal form purity of a beta-HMX crystal form standard substance, which specifically comprises the following steps:
step one, extracting a powder sample;
randomly extracting 7 bottles of samples, dividing, neutralizing and sampling, measuring and numbering the sampling amount according to 3-4 times of the measuring amount, and testing 21 powder samples of the beta-HMX crystal form standard substance in parallel on each component.
Step two, testing beta-HMX, acetone, moisture and other organic impurities in the beta-HMX crystal form standard substance respectively;
the test comprises an X-ray powder diffraction test, a nuclear magnetic resonance test, a warm table-coulomb test and a liquid chromatography test;
performing X-ray powder diffraction test, and calculating by full spectrum fitting to obtain the relative content of the beta-HMX crystal form in all HMX of different crystal forms as shown in figure 1;
nmr testing, as shown in fig. 2, nmr hydrogen spectroscopy was added to a standard method of fumaric acid of known purity for testing acetone content;
a warm-table-coulometric test, as shown in fig. 3, for measuring trace moisture content;
liquid chromatography test, as shown in fig. 4, liquid chromatography normalization was used to test for other organic impurity levels;
specifically, the specific process of the X-ray powder diffraction test comprises the following steps:
step S20101, preparing an alpha-HMX single crystal, dissolving 2g of HMX in 20ml of a mixed solvent of acetone and water according to the volume ratio of 1: 1 to prepare a concentrated solution of HMX, filtering, placing 10ml of filtrate in a test tube, sealing a sealing film, pricking 10-15 holes with a needle, and standing at room temperature until a single crystal grows out;
step S20102, preparing a beta-HMX single crystal, dissolving 6g of HMX in 20ml of a mixed solvent of butyrolactone and dimethyl sulfoxide according to a volume ratio of 73: 27 to prepare a concentrated HMX solution, filtering, placing 10ml of filtrate in a test tube, sealing a sealing film, pricking 10-15 holes with a needle, and standing at room temperature until a single crystal grows out;
the alpha-HMX single crystal and the beta-HMX single crystal are subjected to single crystal X-ray diffraction test to obtain crystal structure parameter data of the alpha-HMX single crystal and the beta-HMX single crystal;
step S20103, placing a 500mg powder sample in an agate mortar, adding 1-2 ml of n-hexane for grinding for 1-2 min in order to inhibit crystal transformation caused by grinding, scraping off the n-hexane with a small spoon, smearing on a glass slide, placing the glass slide under a microscope of 20 times or 50 times for observation, wherein the granularity is 5-10 mu m to inhibit large extinction of crystal particles, and the quantitative sensitivity and the precision are reduced due to diffraction spectrum peak broadening caused by preferred orientation; drying in a vacuum drying oven at 40 ℃ for 3h, standing for 3-4 h for later use, and releasing stress generated by grinding to avoid peak-shaped displacement;
step S20104, performing an X-ray powder diffraction experiment according to the following test parameters: the test parameters of the powder diffractometer are 40kV in voltage, 40mA in current and Cu-K in Cu-KαThe wavelength is 1.5406nm, the sample rotates at the speed of 50 r/min during scanning, the 2 theta scanning starts at the angle of 5 degrees, ends at the angle of 90 degrees, the step width is 0.02 degree, the step time is 1s, each sample is tested on an X-ray powder diffractometer for 1 time, and 1 piece of diffraction spectrum data is obtained;
and step S20105, calculating corresponding standard diffraction spectrums by using TOPAS software according to the alpha-HMX and beta-HMX single crystal structure parameter data and the X-ray powder diffraction data of the standard substance sample, which are obtained in the step S, as input values. Based on the fact that the main crystal form of the sample is beta type, possible mixed crystals are alpha type, the sample is respectively fitted and calculated with alpha type HNIW standard crystal form diffraction spectra, and when the residual variance factor Rwp of a weighting graph is calculated in a fitting mode and is less than 15, the relative content of the beta-HMX crystal form in the sample in alpha type HMX and beta type HMX is obtained.
In this example, single crystals of α -HMX and β -HMX were prepared according to step two, and crystallographic data, bond length and bond angle data were measured on a single crystal diffractometer as shown in tables 1 to 3.
TABLE 1 alpha-HMX, beta-HMX Crystal Structure parameter Table
Figure BDA0002646603910000101
Figure BDA0002646603910000111
TABLE 2 beta-HMX atomic coordinate data
Figure BDA0002646603910000112
TABLE 3 beta-HMX atomic coordinate data
Figure BDA0002646603910000113
Figure BDA0002646603910000121
Taking the crystal structure parameter data and the powder diffraction data in tables 1-3 as input values, and adopting TOPAS software to perform full spectrum fitting calculation on the X-ray powder diffraction spectrum of the sample to obtain the relative content of the beta-HMX in the alpha-HMX and the beta-HMX phases. The test data are counted according to the formula I and the formula II, and the test statistical result is shown in the table 4, wherein the average value of 21 parallel test data is 99.349%, and the experimental standard deviation of the average value is 0.117%.
Table 4 survey of relative content of beta-HMX crystal form fitted to a full spectrum and statistical results table units: % (g/g)
Figure BDA0002646603910000122
Specifically, the specific process of the nuclear magnetic resonance test comprises the following steps:
step S20201, weighing 0.1g of fumaric acid standard substance with known purity, accurately weighing 0.00001g of fumaric acid standard substance, weighing 1000g of deuterated dimethyl sulfoxide, accurately weighing 0.001g of deuterated dimethyl sulfoxide to prepare 0.01% of fumaric acid deuterated dimethyl sulfoxide solution as an internal standard solution, wherein the concentration of the internal standard solution is calculated by the weighed fumaric acid and deuterated dimethyl sulfoxide;
step S20202, weighing 0.1g of beta-HMX crystal form standard substance sample in a nuclear magnetic tube with the diameter of 5mm, accurately measuring the sample to 0.00001g, adding 0.6g of prepared fumaric acid solution with the volume of 0.5-0.6 ml, accurately measuring the sample to 0.0001g, sealing the sample by using a nuclear magnetic cap and a sealing film, performing ultrasonic treatment for 3-5 min, and then performing quantitative nuclear magnetic hydrogen spectrum test; the quantitative nuclear magnetic test conditions were: the resonance frequency of a nuclear magnetic spectrometer is 400-800 MHz, the temperature is 20-35 ℃, the delay time is not less than 10s, the pulse angle is 30-90 degrees, and the sampling frequency is not less than 16 times;
H2.27 is a characteristic peak of 6H on acetone,H6.06 shows a characteristic peak of 2H on fumaric acid-HC ═ CH-H6.05 is the characteristic peak for H on the HMX ring. The intensity ratio of 6 hydrogen of 1 molecule of acetone to 2 hydrogen of 1 molecule of fumaric acid is equivalent to the molar ratio of the two components, and according to the obtained nuclear magnetic spectrum, after integral treatment, the acetone content is calculated by a formula I:
Figure BDA0002646603910000131
in the formula:
X2-the content of residual solvent acetone in the sample, expressed as mass fraction;
As-integrated area of characteristic signal peak of fumaric acid;
Ax-integrated area of acetone characteristic peak;
H s1 molecule of fumaric acid characteristic peak corresponding to the number of H on the functional group, 2;
H x1, the number of H on the functional group corresponding to the characteristic peak of the molecular acetone is 6;
Mx-acetone molecular weight, 58.08;
Msfumaric acid molecular weight, 116.07;
msmass of fumaric acid solution in g;
mass of m-beta-HMX sample in g;
Psconcentration in grams/g of fumaric acid solution.
In this example, the test data are counted according to formula i and formula ii, and the test statistics are shown in table 5, wherein the average value of 21 parallel test data is 0.006%, and the standard deviation of the test of the average value is 0.0001%.
Table 5 nmr hydrogen spectra versus acetone test and statistics table units: % (g/g)
Figure BDA0002646603910000141
Specifically, the specific process of the warm table-coulomb test comprises the following steps:
step S203, weighing 1g of sample by using a warm table sample bottle, accurately measuring the sample to 0.002g, and sealing the sample in a warm table; setting the heating temperature at 220 ℃, keeping the temperature for 10min, starting a titration switch, and correspondingly consuming 10.712 coulomb electricity by 1g of water, wherein the water content can be calculated according to the consumed electricity.
In this example, the test data are counted according to formula I and formula II, and the test statistics are shown in Table 6. The mean of 21 replicates was 0.0627%, with an experimental standard deviation of 0.0024% for the mean.
Table 6 table unit of results of bench-coulometry on trace moisture test and statistics: % (g/g)
Figure BDA0002646603910000142
Specifically, the specific process of the liquid chromatography test comprises the following steps:
step S204, weighing about 0.01g of sample to be accurate to 0.0002g, dissolving the sample with 1ml of acetonitrile, and diluting the sample with methanol to 50ml for chromatographic analysis; liquid chromatography ultraviolet detectionWavelength of the device is selected to be 220nm, and a chromatographic column SB-C18(Φ 4.6mm × 250mm), mobile phase V (methanol): v (water) is 60: 40, the flow rate is 1mL/min, and the sample injection amount is 5 mul; and comparing the blank of the acetonitrile methanol solution with the chromatogram of the sample solution, selecting all peaks except a solvent peak for area normalization, and calculating the content of organic impurities in the beta-HMX crystal form standard substance.
In this example, the test data were counted according to formulas I and II, and the test statistics are shown in Table 7. The mean of 21 replicates was 0.196% and the experimental standard deviation of the mean was 0.016%.
Table 7 liquid chromatography on organic impurities test and statistics table units: % (g/g)
Figure BDA0002646603910000143
And step three, carrying out statistical analysis on the test results of the beta-HMX, acetone, moisture and other organic impurities in the beta-HMX crystal form standard substance to obtain a fixed value result.
The fixed value result of the crystal form purity of the beta-HMX crystal form standard substance is determined by the crystal form purity xβ-HMXAnd uncertainty uβ-HMXAnd (4) forming.
The specific process for obtaining the fixed value result through data statistics comprises the following steps:
step S301, counting the purity value of the crystal form:
the purity of the beta-HMX crystal form is that acetone, moisture and other organic impurities are subtracted from the content of beta-HMX in two phases of alpha-HMX and beta-HMX, and a calculation formula is shown as a formula II;
Figure BDA0002646603910000151
in the formula:
xβ-HMXthe purity of the beta-HMX crystal form is expressed by mass percent;
Figure BDA0002646603910000152
the average value of the relative content test results of the beta-HMX crystal form is obtained;
Figure BDA0002646603910000153
is the average of the acetone test results;
Figure BDA0002646603910000154
the average value of the moisture test results;
Figure BDA0002646603910000155
the average value of the test results of other organic impurities;
step S302, uncertainty statistics:
the uncertainty of the purity of the beta-HMX crystal form is synthesized by the uncertainty of the test of four components, and the uncertainty introduced in the test process of each component is composed of random factors and fixed factors, wherein:
the calculation formula of the experimental standard deviation of the average value of the four types of components is shown in a formula III;
Figure BDA0002646603910000156
the uncertainty introduced by the random factors is synthesized by the experimental standard deviation of the average value of the four components, and the formula is calculated and shown as the formula IV;
Figure BDA0002646603910000161
in the formula: sβ-HMXUncertainty introduced for random factors;
Figure BDA0002646603910000162
is the experimental standard deviation of the mean value of the purity test of the beta-HMX crystal form;
Figure BDA0002646603910000163
experimental standard deviation which is the mean of the acetone content test;
Figure BDA0002646603910000164
experimental standard deviation which is the mean of the moisture content test;
Figure BDA0002646603910000165
experimental standard deviation of the mean values tested for other organic impurities;
the uncertainty introduced by the fixed factor is only the uncertainty of an internal standard substance when the acetone is subjected to fixed value by nuclear magnetism, and the uncertainties introduced by the fixed factors of other three components are ignored, so that the fixed value uncertainty is the uncertainty introduced by the random factor and the fixed factor, and the calculation formula is shown as a formula V;
Figure BDA0002646603910000166
in the formula:
uβ-HMXuncertainty for crystal form purity;
uRthe uncertainty of fumaric acid for nuclear magnetic testing is 0.00102%.
In this example, uncertainty analysis was performed on the rating results of each step according to formula iii, formula iv, and formula v in step three, and the rating results are shown in table 8. The fixed value result of the crystal form purity of the beta-HMX crystal form standard substance is as follows: 99.08% ± 0.24% (k ═ 2, P ═ 95%)
Table 8 β -HMX crystal form purity fixed value statistical results table units: % (g/g)
Figure BDA0002646603910000167
Figure BDA0002646603910000171

Claims (8)

1. A method for determining a crystal form purity value of a beta-HMX crystal form standard substance is characterized by comprising the following steps:
step one, extracting a powder sample;
step two, testing beta-HMX, acetone, moisture and other organic impurities in the beta-HMX crystal form standard substance respectively;
the test comprises an X-ray powder diffraction test, a nuclear magnetic resonance test, a warm table-coulomb test and a liquid chromatography test;
testing X-ray powder diffraction, and calculating by full spectrum fitting to obtain the relative content of the beta-HMX crystal form in all HMX of different crystal forms;
nuclear magnetic resonance testing, wherein a nuclear magnetic resonance hydrogen spectrum is added with a fumaric acid standard method with known purity for testing the content of acetone;
warm stage-coulomb test, warm stage-coulomb titration method is used for testing the trace moisture content;
liquid chromatography test, wherein a liquid chromatography normalization method is used for testing the content of other organic impurities;
and step three, carrying out statistical analysis on the test results of the beta-HMX, acetone, moisture and other organic impurities in the beta-HMX crystal form standard substance to obtain a fixed value result.
2. The method for quantifying the crystal form purity of a beta-HMX crystal form standard according to claim 1, wherein the quantification of the crystal form purity of the beta-HMX crystal form standard results from the crystal form purity xβ-HMXAnd uncertainty uβ-HMXAnd (4) forming.
3. The method for determining the crystal form purity of the beta-HMX crystal form standard substance according to claim 1, wherein in the step one, 7 bottles of samples are randomly extracted, divided, neutralized and sampled, the sampling amount is measured and numbered according to 3-4 times of the measurement amount, and 21 powder samples of the beta-HMX crystal form standard substance are parallelly tested for each component.
4. The method for determining the crystal form purity of the beta-HMX crystal form standard substance according to claim 1, wherein in the second step, the specific process of the X-ray powder diffraction test comprises the following steps:
step S20101, preparing an alpha-HMX single crystal, dissolving 2g of HMX in 20ml of a mixed solvent of acetone and water according to the volume ratio of 1: 1 to prepare a concentrated solution of HMX, filtering, placing 10ml of filtrate in a test tube, sealing a sealing film, pricking 10-15 holes with a needle, and standing at room temperature until a single crystal grows out;
step S20102, preparing a beta-HMX single crystal, dissolving 6g of HMX in 20ml of a mixed solvent of butyrolactone and dimethyl sulfoxide according to a volume ratio of 73: 27 to prepare a concentrated HMX solution, filtering, placing 10ml of filtrate in a test tube, sealing a sealing film, pricking 10-15 holes with a needle, and standing at room temperature until a single crystal grows out;
the alpha-HMX single crystal and the beta-HMX single crystal are subjected to single crystal X-ray diffraction test to obtain crystal structure parameter data of the alpha-HMX single crystal and the beta-HMX single crystal;
step S20103, placing a 500mg powder sample in an agate mortar, adding 1-2 ml of n-hexane for grinding for 1-2 min in order to inhibit crystal transformation caused by grinding, scraping off the n-hexane with a small spoon, smearing on a glass slide, placing the glass slide under a microscope of 20 times or 50 times for observation, wherein the granularity is 5-10 mu m to inhibit large extinction of crystal particles, and the quantitative sensitivity and the precision are reduced due to diffraction spectrum peak broadening caused by preferred orientation; drying in a vacuum drying oven at 40 ℃ for 3h, standing for 3-4 h for later use, and releasing stress generated by grinding to avoid peak-shaped displacement;
step S20104, performing an X-ray powder diffraction experiment according to the following test parameters: the test parameters of the powder diffractometer are 40kV in voltage, 40mA in current and Cu-K in Cu-KαThe wavelength is 1.5406nm, the sample rotates at the speed of 50 r/min during scanning, the 2 theta scanning starts at the angle of 5 degrees, ends at the angle of 90 degrees, the step width is 0.02 degree, the step time is 1s, each sample is tested on an X-ray powder diffractometer for 1 time, and 1 piece of diffraction spectrum data is obtained;
and step S20105, calculating corresponding standard diffraction spectrums by using TOPAS software according to the alpha-HMX and beta-HMX single crystal structure parameter data and the X-ray powder diffraction data of the standard substance sample, which are obtained in the step S, as input values. Based on the fact that the main crystal form of the sample is beta type, possible mixed crystals are alpha type, the sample is respectively fitted and calculated with alpha type HNIW standard crystal form diffraction spectra, and when the residual variance factor Rwp of a weighting graph is calculated in a fitting mode and is less than 15, the relative content of the beta-HMX crystal form in the sample in alpha type HMX and beta type HMX is obtained.
5. The method for determining the crystal form purity of the beta-HMX crystal form standard substance according to claim 1, wherein in the second step, the specific process of the nuclear magnetic resonance test comprises the following steps:
step S20201, weighing 0.1g of fumaric acid standard substance with known purity, accurately weighing 0.00001g of fumaric acid standard substance, weighing 1000g of deuterated dimethyl sulfoxide, accurately weighing 0.001g of deuterated dimethyl sulfoxide to prepare 0.01% of fumaric acid deuterated dimethyl sulfoxide solution as an internal standard solution, wherein the concentration of the internal standard solution is calculated by the weighed fumaric acid and deuterated dimethyl sulfoxide;
step S20202, weighing 0.1g of beta-HMX crystal form standard substance sample in a nuclear magnetic tube with the diameter of 5mm, accurately measuring the sample to 0.00001g, adding 0.6g of prepared fumaric acid solution with the volume of 0.5-0.6 ml, accurately measuring the sample to 0.0001g, sealing the sample by using a nuclear magnetic cap and a sealing film, performing ultrasonic treatment for 3-5 min, and then performing quantitative nuclear magnetic hydrogen spectrum test; the quantitative nuclear magnetic test conditions were: the resonance frequency of a nuclear magnetic spectrometer is 400-800 MHz, the temperature is 20-35 ℃, the delay time is not less than 10s, the pulse angle is 30-90 degrees, and the sampling frequency is not less than 16 times;
H2.27 is a characteristic peak of 6H on acetone,H6.06 shows a characteristic peak of 2H on fumaric acid-HC ═ CH-H6.05 characteristic peak for H on HMX ring; the intensity ratio of 6 hydrogen of 1 molecule of acetone to 2 hydrogen of 1 molecule of fumaric acid is equivalent to the molar ratio of the two components, and according to the obtained nuclear magnetic spectrum, after integral treatment, the acetone content is calculated by a formula I:
Figure FDA0002646603900000031
in the formula:
X2-the content of residual solvent acetone in the sample, expressed as mass fraction;
As-integrated area of characteristic signal peak of fumaric acid;
Ax-integrated area of acetone characteristic peak;
Hs1 molecule of fumaric acid characteristic peak corresponding to the number of H on the functional group, 2;
Hx1, the number of H on the functional group corresponding to the characteristic peak of the molecular acetone is 6;
Mx-acetone molecular weight, 58.08;
Msfumaric acid molecular weight, 116.07;
msmass of fumaric acid solution in g;
mass of m-beta-HMX sample in g;
Psconcentration in grams/g of fumaric acid solution.
6. The method for determining the crystal form purity of the beta-HMX crystal form standard substance according to claim 1, wherein in the second step, the specific process of the warm stage-coulomb test comprises the following steps:
step S203, weighing 1g of sample by using a warm table sample bottle, accurately measuring the sample to 0.002g, and sealing the sample in a warm table; setting the heating temperature at 220 ℃, keeping the temperature for 10min, starting a titration switch, and correspondingly consuming 10.712 coulomb electricity by 1g of water, wherein the water content can be calculated according to the consumed electricity.
7. The method for determining the crystal form purity of the beta-HMX crystal form standard substance according to claim 1, wherein in the second step, the specific process of the liquid chromatography test comprises the following steps:
step S204, weighing about 0.01g of sample to be accurate to 0.0002g, dissolving the sample with 1ml of acetonitrile, and diluting the sample with methanol to 50ml for chromatographic analysis; wavelength of liquid chromatography ultraviolet detector is selected to be 220nm, and chromatographic column SB-C18(Φ 4.6mm × 250mm), mobile phase V (methanol): v (water) is 60: 40, the flow rate is 1mL/min, and the sample injection amount is 5 mul; by passingAnd comparing the blank of the acetonitrile methanol solution with the chromatogram of the sample solution, selecting all peaks except the solvent peak for area normalization, and calculating the content of organic impurities in the beta-HMX crystal form standard substance.
8. The method for valuing the crystal form purity of the beta-HMX crystal form standard substance according to claim 1, wherein in the third step, the specific process of obtaining a value-fixing result through data statistics comprises the following steps:
step S301, counting the purity value of the crystal form:
the purity of the beta-HMX crystal form is that acetone, moisture and other organic impurities are subtracted from the content of beta-HMX in two phases of alpha-HMX and beta-HMX, and a calculation formula is shown as a formula II;
Figure FDA0002646603900000051
in the formula:
xβ-HMXthe purity of the beta-HMX crystal form is expressed by mass percent;
Figure FDA0002646603900000052
the average value of the relative content test results of the beta-HMX crystal form is obtained;
Figure FDA0002646603900000053
is the average of the acetone test results;
Figure FDA0002646603900000054
the average value of the moisture test results;
Figure FDA0002646603900000055
the average value of the test results of other organic impurities;
step S302, uncertainty statistics:
the uncertainty of the purity of the beta-HMX crystal form is synthesized by the uncertainty of the test of four components, and the uncertainty introduced in the test process of each component is composed of random factors and fixed factors, wherein:
the calculation formula of the experimental standard deviation of the average value of the four types of components is shown in a formula III;
Figure FDA0002646603900000056
the uncertainty introduced by the random factors is synthesized by the experimental standard deviation of the average value of the four components, and the formula is calculated and shown as the formula IV;
Figure FDA0002646603900000057
in the formula:
sβ-HMXuncertainty introduced for random factors;
Figure FDA0002646603900000061
is the experimental standard deviation of the mean value of the purity test of the beta-HMX crystal form;
Figure FDA0002646603900000062
experimental standard deviation which is the mean of the acetone content test;
Figure FDA0002646603900000063
experimental standard deviation which is the mean of the moisture content test;
Figure FDA0002646603900000064
experimental standard deviation of the mean values tested for other organic impurities;
the uncertainty introduced by the fixed factor is only the uncertainty of an internal standard substance when the acetone is subjected to fixed value by nuclear magnetism, and the uncertainties introduced by the fixed factors of other three components are ignored, so that the fixed value uncertainty is the uncertainty introduced by the random factor and the fixed factor, and the calculation formula is shown as a formula V;
Figure FDA0002646603900000065
in the formula:
uβ-HMXuncertainty for crystal form purity;
uRthe uncertainty of fumaric acid for nuclear magnetic testing is 0.00102%.
CN202010856686.XA 2020-08-24 2020-08-24 Method for determining crystal form purity of beta-HMX crystal form standard substance Active CN112067642B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010856686.XA CN112067642B (en) 2020-08-24 2020-08-24 Method for determining crystal form purity of beta-HMX crystal form standard substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010856686.XA CN112067642B (en) 2020-08-24 2020-08-24 Method for determining crystal form purity of beta-HMX crystal form standard substance

Publications (2)

Publication Number Publication Date
CN112067642A true CN112067642A (en) 2020-12-11
CN112067642B CN112067642B (en) 2022-10-25

Family

ID=73659393

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010856686.XA Active CN112067642B (en) 2020-08-24 2020-08-24 Method for determining crystal form purity of beta-HMX crystal form standard substance

Country Status (1)

Country Link
CN (1) CN112067642B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112666195A (en) * 2020-12-29 2021-04-16 西安近代化学研究所 HMX crystal molecular dynamics simulation precision improving method and single crystal structure preparation method

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973149A (en) * 1997-10-29 1999-10-26 Snpe Process for producing the epsilon polymorphic form of hexanitrohexaazaisowurtzitane
CN103792222A (en) * 2014-02-17 2014-05-14 中国工程物理研究院化工材料研究所 Quantitative determination method for crystal forms of hexanitrohexaazaisowurtzitane
CN104592184A (en) * 2014-12-15 2015-05-06 云南省药物研究所 Scutellarin aglycone crystal forms and preparation method thereof
US20180024085A1 (en) * 2016-07-19 2018-01-25 The Government Of The United States Of America, As Represented By The Secretary Of The Navy 2h to 1t phase based transition metal dichalcogenide sensor for optical and electronic detection of strong electron donor chemical vapors
CN107632105A (en) * 2017-08-31 2018-01-26 中国农业科学院农业质量标准与检测技术研究所 Ornidazole purity rubric material and preparation method and application
CN110530817A (en) * 2019-09-03 2019-12-03 西安近代化学研究所 A kind of β-HMX crystal form purity detection method of the spectral technology that diffuses infrared based in
CN110579500A (en) * 2019-09-12 2019-12-17 西安近代化学研究所 beta-HMX crystal form purity detection method based on X-ray powder diffraction technology
CN111007098A (en) * 2019-12-18 2020-04-14 西安近代化学研究所 Quantitative nuclear magnetic hydrogen spectrum value determination method for 2,4, 6-trinitrotoluene standard substance

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973149A (en) * 1997-10-29 1999-10-26 Snpe Process for producing the epsilon polymorphic form of hexanitrohexaazaisowurtzitane
CN103792222A (en) * 2014-02-17 2014-05-14 中国工程物理研究院化工材料研究所 Quantitative determination method for crystal forms of hexanitrohexaazaisowurtzitane
CN104592184A (en) * 2014-12-15 2015-05-06 云南省药物研究所 Scutellarin aglycone crystal forms and preparation method thereof
US20180024085A1 (en) * 2016-07-19 2018-01-25 The Government Of The United States Of America, As Represented By The Secretary Of The Navy 2h to 1t phase based transition metal dichalcogenide sensor for optical and electronic detection of strong electron donor chemical vapors
CN107632105A (en) * 2017-08-31 2018-01-26 中国农业科学院农业质量标准与检测技术研究所 Ornidazole purity rubric material and preparation method and application
CN110530817A (en) * 2019-09-03 2019-12-03 西安近代化学研究所 A kind of β-HMX crystal form purity detection method of the spectral technology that diffuses infrared based in
CN110579500A (en) * 2019-09-12 2019-12-17 西安近代化学研究所 beta-HMX crystal form purity detection method based on X-ray powder diffraction technology
CN111007098A (en) * 2019-12-18 2020-04-14 西安近代化学研究所 Quantitative nuclear magnetic hydrogen spectrum value determination method for 2,4, 6-trinitrotoluene standard substance

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
张皋等: "黑索今纯度标准物质的研究", 《化学分析计量》 *
徐金江: "CL-20重结晶过程中的晶型转变研究", 《中国优秀博硕士学位论文全文数据库(硕士)工程科技Ⅰ辑》 *
黄新萍等: "纯度标准物质HMX的制备及均匀性检验", 《火炸药学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112666195A (en) * 2020-12-29 2021-04-16 西安近代化学研究所 HMX crystal molecular dynamics simulation precision improving method and single crystal structure preparation method

Also Published As

Publication number Publication date
CN112067642B (en) 2022-10-25

Similar Documents

Publication Publication Date Title
CN112305007B (en) Method for measuring deuterium isotope abundance of deuterium labeled compound by using nuclear magnetic hydrogen spectrum or deuterium spectrum
CN110487612A (en) A kind of schizandrin A purity rubric substance and the preparation method and application thereof
CN107300565B (en) The NMR spectrum method of rice syrup is mixed in a kind of quick identification honey
CN109030538B (en) Method for measuring nitroglycerin moisture content by nuclear magnetic resonance hydrogen spectrum
CN102520079B (en) Method for rapidly measuring content of solanesol in tobaccos by using UPLC (Ultra Performance Liquid Chromatography)
CN112067642B (en) Method for determining crystal form purity of beta-HMX crystal form standard substance
CN115184497B (en) Method for determining content of 2, 4-epibrassinolide in dendrobium candidum
CN109030539B (en) Method for measuring moisture content of 1, 5-diazido-3-nitro-3-aza pentane by nuclear magnetic resonance hydrogen spectrum
CN109239120B (en) Method for measuring moisture content of 1, 2-propylene glycol dinitrate by nuclear magnetic resonance hydrogen spectrum
CN105510504B (en) Method for measuring imidazole, musk xylene and sesamol residue quantity in edible essence
CN112067641B (en) Method for determining crystal form purity of alpha-HMX crystal form standard substance
CN101929959A (en) Method for analyzing and detecting lead impurity element in beryllium-aluminum alloy
CN112067640B (en) Crystal form purity value-defining method for epsilon-HNIW crystal form standard substance
CN112098444B (en) Gamma-HNIW crystal form standard substance crystal form purity value determination method
CN112098623B (en) Method for determining crystal form purity value of alpha-HNIW crystal form standard substance
CN112557432A (en) Content determination method of bis- (N-bis (dimethylamino) methylene) -chloridized imine salt catalyst
CN106841474A (en) The extraction of the peculiar N nitrosamine of tobacco and assay method in a kind of tobacco or tobacco product based on hydrophobic nonionic exchange SPE
CN108398452A (en) A method of ginsenoside Re's reference substance content is measured based on proton magnetic quantitative analysis tech
CN113740198B (en) Method for measuring yellow vaseline content in musk hemorrhoid ointment
CN108490102A (en) A kind of nicotine standard substance and preparation method, nicotine solution standard substance and application
CN109030540B (en) Method for measuring water content of diethylene glycol dinitrate and nitroglycerin mixed nitrate by nuclear magnetic resonance hydrogen spectrum
CN109030535B (en) Method for measuring moisture content of diethylene glycol dinitrate by hydrogen nuclear magnetic resonance spectroscopy
CN109030536B (en) Method for measuring water content of triethylene glycol dinitrate and nitroglycerin mixed nitrate by nuclear magnetic resonance hydrogen spectrum
CN109030537B (en) Method for measuring water content of mixed nitrate of butanetriol trinitrate and nitroglycerin by nuclear magnetic resonance hydrogen spectroscopy
CN112649545A (en) Method for quantitatively detecting saponin compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant